Liver-specific silencing of MCJ reduces steatosis, inflammation and fibrosis in NASH mouse models July 13, 2020
Reduction in enrollment in phase II trial of lanifibranor in patients with type 2 diabetes and NAFLD July 6, 2020
RSS